Full-Time

UI Developer

Posted on 6/21/2025

Amgen

Amgen

10,001+ employees

Develops biologic therapies for serious illnesses

No salary listed

Junior, Mid, Senior

Hyderabad, Telangana, India

Category
Product & UX/UI Design
UI/UX & Design
Required Skills
Agile
JavaScript
React.js
Git
Node.js
Jest
SCRUM
AngularJS
HTML/CSS
Requirements
  • Master’s degree and 1 to 3 years of experience in Computer Science, IT, or a related field OR
  • Bachelor’s degree with 3 - 5 years of experience in Computer Science, IT, or a related field OR
  • Diploma with 7 - 9 years of experience in Computer Science, IT, or a related field
  • Strong knowledge of information systems and network technologies.
  • Proficiency in programming languages such as JavaScript (preferred), HTML/CSS.
  • Strong understanding of software development methodologies, including Agile and Scrum.
  • Experience with version control systems like Git.
  • Experience with front-end frameworks such as React.js or Angular.js.
  • Experience with responsive and adaptive design principles.
  • Knowledge of UI/UX best practices and design patterns.
  • Experience with UI testing frameworks such as Jest, Enzyme, or Cypress.
  • Experience with modern front-end frameworks and libraries (e.g., React, Node.js), and expertise in building responsive and user-friendly UIs.
Responsibilities
  • Take ownership of complex software projects from conception to deployment.
  • Manage software delivery scope, risk, and timeline.
  • Possess strong rapid prototyping skills and can quickly translate concepts into working code.
  • Contribute to front-end development using cloud technology.
  • Develop innovative solutions using generative AI technologies.
  • Conduct code reviews to ensure code quality and adherence to best practices.
  • Create and maintain documentation on software architecture, design, deployment, disaster recovery, and operations.
  • Identify and resolve technical challenges effectively.
  • Stay updated with the latest trends and advancements in UI development.
  • Work closely with the product team, business team, and other stakeholders.
  • Design, develop, and implement user interfaces and modules, including custom reports, interfaces, and enhancements.
  • Analyze and understand the functional and technical requirements of applications, solutions, and systems and translate them into software architecture and design specifications.
  • Develop and execute unit tests, integration tests, and other testing strategies to ensure the quality of the software.
  • Identify and resolve software bugs and performance issues.
  • Work closely with cross-functional teams, including product management, design, and QA, to deliver high-quality software on time.
  • Maintain detailed documentation of software designs, code, and development processes.
  • Customize modules to meet specific business requirements.
  • Work on integrating with other systems and platforms to ensure seamless data flow and functionality.
  • Provide ongoing support and maintenance for applications, ensuring that they operate smoothly and efficiently.
  • Develop intuitive and responsive user interfaces (UIs) that enable users to efficiently interact with multiple datasets, leveraging modern front-end frameworks and libraries.
  • Collaborate with UX designers to translate design mockups and wireframes into interactive and visually appealing user interfaces.
  • Implement UI animations and transitions to enhance the user experience and provide feedback to users.
  • Optimize UI performance by identifying and addressing bottlenecks, ensuring smooth and fast interactions.
  • Ensure accessibility standards are met, making the UI usable for people with disabilities.
  • Participate in Agile ceremonies (Daily Scrum/Refinement/Retro) to partner with the product owner and team to discuss, set, and deliver two-week developmental goals.
  • Keep abreast of technology upgrades and advancements and provide recommendations to improve process efficiencies.
Desired Qualifications
  • Strong understanding of cloud platforms (e.g., AWS, GCP, Azure) and containerization technologies (e.g., Docker).
  • Experience with monitoring and logging tools (e.g., Prometheus, Grafana).
  • Experience with data processing tools like Hadoop or similar.
  • Experience with UI performance optimization techniques.
  • Familiarity with accessibility standards and tools for testing accessibility.
  • Knowledge of data governance principles and familiarity with Great Expectations for data validation.
  • Hands-on experience building data pipelines using applications like Databricks.
  • Solid grasp of infrastructure as code, developing and operating programmatic pipelines for cloud services, and using automated DevSecOps frameworks to run a cloud SDLC.
  • Knowledge or experience in basic DevOps support and deployment including Docker, Kubernetes, CICD, etc.

Amgen develops medicines aimed at treating serious illnesses, focusing on biotechnology. The company researches, develops, and sells biologic therapies, which are medicines made from living organisms. These therapies target conditions like cancer, cardiovascular diseases, and autoimmune disorders. Amgen's approach involves a strong commitment to research and development, allowing them to create new treatments and maintain a pipeline of potential therapies. Unlike many competitors, Amgen emphasizes biologic therapies and reinvests a large portion of its earnings back into R&D. The goal of Amgen is to improve patient care by providing effective treatments for serious health conditions.

Company Size

10,001+

Company Stage

IPO

Headquarters

Thousand Oaks, California

Founded

1980

Simplify Jobs

Simplify's Take

What believers are saying

  • Acquisition of Micromet boosts Amgen's oncology portfolio with BiTE antibody blinatumomab.
  • Institutional investments indicate strong confidence in Amgen's financial health and prospects.
  • Amgen's AI-driven drug discovery investments could accelerate R&D capabilities.

What critics are saying

  • Micromet acquisition may face clinical or regulatory challenges impacting strategic goals.
  • Investor pressure for short-term gains may affect long-term R&D investments.
  • FTC scrutiny on mergers could hinder Amgen's future strategic growth.

What makes Amgen unique

  • Amgen focuses on biologic therapies derived from living organisms.
  • The company has a strong pipeline in oncology, cardiovascular, and autoimmune disorders.
  • Amgen's strategic acquisitions enhance its innovative medicine portfolio.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Professional Development Budget

Conference Attendance Budget

Company News

Amgen
Jun 2nd, 2025
Amgen to Acquire Micromet| Amgen

The acquisition includes blinatumomab, a Bispecific T cell Engager (BiTE) antibody in Phase 2 clinical development for acute lymphoblastic leukemia (ALL). Blinatumomab is also in clinical development for the treatment of non-Hodgkin's lymphoma (NHL), and could have applications in other hematologic malignancies.

MarketBeat
Jan 28th, 2024
Factory Mutual Insurance Co. Makes New Investment in Amgen Inc. (NASDAQ:AMGN)

Factory Mutual Insurance Co. purchased a new position in Amgen Inc. (NASDAQ:AMGN - Free Report) during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm purchased 53,500 shares of the medical research company's stock, valued at approxim

The Quantum Insider
Jan 16th, 2024
Honeywell Announces the Closing of $300 Million Equity Investment Round for Quantinuum at $5 Billion Pre-Money Valuation

JPMorgan Chase has one of the world's most highly regarded specialist teams working on quantum technologies within the financial services industry and has been working with Quantinuum and its predecessor companies since 2020.

ETF Daily News
Dec 17th, 2023
Northwest Quadrant Wealth Management LLC Invests $237,000 in Amgen Inc. (NASDAQ:AMGN)

Northwest Quadrant Wealth Management LLC bought a new position in shares of Amgen Inc. (NASDAQ:AMGN – Free Report) during the third quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund bought 883 shares of the medical research company’s stock, valued at approximately $237,000. A number of other institutional investors […]

Horizon Therapeutics
Sep 21st, 2023
Rule 2.7 Announcement: Amgen Inc to Acquire Horizon Therapeutics plc | Horizon Therapeutics plc

The Investor Relations website contains information about Horizon Therapeutics plc's business for stockholders, potential investors, and financial analysts.